Similar findings have been reported by Harris and coworkers (105) in which co-treatment of sEH inhibitor with DHA diminished the therapeutic effects of TPPU alone in a murine model of liver fibrosis. The gene discussed is EPHX2; the disease is Hepatic fibrosis.